By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1971 Old Cuthbert Road

Cherry Hill  New Jersey  08034  U.S.A.
Phone: 856-433-6088 Fax: 856-354-1077



Company News
Nuvilex (NVLX) Executives In Southeast Asia To Further Advance Cell-In-A-Box Technology 11/21/2014 2:41:40 PM
Nuvilex (NVLX) Announces Preliminary Data From Preclinical Study of Effects of Its Pancreatic Cancer Treatment on Ascites Fluid Formation 11/19/2014 9:36:30 AM
Nuvilex (NVLX) Applies In Australia For The Orphan Drug Designation For Pancreatic Cancer Treatment 11/7/2014 10:43:41 AM
Nuvilex (NVLX) Contracts With University Of Veterinary Medicine In Vienna To Conduct Preclinical Studies On The Use Of Cell-In-A Box® To Develop Diabetes Treatment 10/20/2014 7:30:52 AM
Nuvilex (NVLX) Secures Worldwide License For Insulin-Producing Cells From University of Technology Sydney, For Use In Developing Diabetes Treatment 10/16/2014 7:49:40 AM
Nuvilex (NVLX) Applies To FDA For Orphan Drug Designation For Its Cell-In-A-Box® Treatment For Pancreatic Cancer 10/13/2014 8:20:43 AM
Nuvilex (NVLX) Announces Strategic Changes To Leadership Team And Appoints Prof. Dr. Walter H. Gunzburg As Chief Scientific Officer 10/1/2014 10:10:57 AM
Nuvilex (NVLX)'s Partner, Austrianova, Publishes Scientific Review Article Emphasizing Use Of Cell-In-A-Box® For Treatment Of Diabetes 9/22/2014 8:06:20 AM
Nuvilex (NVLX) Updates Shareholders On Recent Activities And Discusses Future Plans For Development Of Treatments For Cancer And Diabetes 9/18/2014 11:29:48 AM
Nuvilex (NVLX)'s Partner, Austrianova, Receives Prestigious Emerging Enterprises 2014 Best Innovation Award In Singapore 9/8/2014 7:28:11 AM